To ensure the tumour-targeting ability of the two-in-one backbone remained intact, A431 cells were examined that are both positive for EGFR and PD-L1, revealing very similar on-cell affinities for all variants (Supplementary Table 1; Supplementary Figure 3). The gene discussed is CD274; the disease is neoplasm.